Swan alcohol recalled for insanitary conditions and rodent exposure
Swan White Clear Alcohol (50%, 16oz bottles) distributed nationwide is being recalled due to insanitary conditions including rodent exposure and activity in the distribution center.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall involves CGMP deviations, insanitary conditions, and evidence of rodent exposure in the distribution center. As a risk-of-harm product with no reported illnesses or injuries in the source, it meets the criteria for a High severity score.
Plain-English summary
Swan White Clear Alcohol, a 50% ABV spirit distributed in 16-ounce bottles sold in 12-count packages, is being recalled. The product has been distributed nationwide.
The FDA is conducting this Class II recall due to Current Good Manufacturing Practice (CGMP) deviations at the distribution center operated by Gold Star Distribution Inc. The deviations include insanitary conditions and evidence of rodent exposure and activity in the facility.
Consumers who have purchased this product should not consume it. Anyone who has consumed the product or has questions about the recall should contact Gold Star Distribution Inc. or consult with a healthcare provider.
The recalled product
- Product
- Swan, White Clear Alcohol, 50%, 16oz, 12 count
- Manufacturer
- GOLD STAR DISTRIBUTION INC
- Category
- Drug — Distilled Spirit
- Hazard
- rodent-exposure
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry distributed by Gold Star Distribution.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27